Suchergebnisse - "Benlarbi, Mehdi"

PubPharm (13)

1

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

enthalten in: bioRxiv.org | 2023

von Tauzin, A. | Gong, S. | Beaudoin-Bussières, G. | +34

2

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV

enthalten in: Viruses | 2023

von Marchitto, L. | Chatterjee, D. | Ding, S. | +10

3

Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine

enthalten in: Viruses | 2023

von Tauzin, A. | Beaudoin-Bussières, G. | Benlarbi, M. | +15

4

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity

enthalten in: mBio | 2023

von Marchitto, L. | Benlarbi, M. | Prévost, J. | +10

5

Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia

enthalten in: bioRxiv.org | 2023

von Benlarbi, M. | Richard, J. | Bourassa, C. | +25

6

Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Benlarbi, M. | Richard, J. | Bourassa, C. | +27

UpdateIn: J Infect Dis. 2023 Nov 30;:. - PMID 38035854

7

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

enthalten in: bioRxiv.org | 2023

von Brunet-Ratnasingham, E. | Morin, S. | Randolph, H. | +41

8

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

enthalten in: Cell chemical biology | 2023

von Richard, J. | Prévost, J. | Bourassa, C. | +16

9

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

enthalten in: Cell reports. Medicine | 2023

von Sannier, G. | Nicolas, A. | Dubé, M. | +35

10

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine

enthalten in: Cell reports | 2023

von Tauzin, A. | Nicolas, A. | Ding, S. | +20